Exclusively dedicated to the development of medicines for patients with rare unmet needs.
Cerium Pharmaceuticals, Inc. is an emerging biopharmaceutical company dedicated to the development and commercialization of medicines for patients with rare (orphan) diseases. Cerium’s core focus is to acquire currently marketed products and mid-to-late stage development compounds for rare diseases, leveraging basic discovery work already performed by others that has established project feasibility. Cerium’s unique business model pairs a core management team of rare disease experts; with an extensive network of academic researchers, specialized consultants, third party service providers and contractors. We have expertise in clinical development, regulatory affairs, and commercialization of rare disease medicines. Based on our extensive and successful experience, we employ an optimized infrastructure to quickly develop and commercialize new orphan medicines.